Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
screening
MedTech
FDA approves Guardant’s colorectal cancer screening blood test
While it won't replace a colonoscopy, the Shield test is designed to funnel adults ages 45 and up at an average risk for the disease toward the exam.
Conor Hale
Jul 29, 2024 11:00am
FDA panel gives OK to Guardant's colorectal cancer blood test
May 23, 2024 5:15pm
Beyond A, B, O: Thermo Fisher unveils test for rare blood types
May 16, 2024 12:30pm
Guardant preps for FDA review of colorectal cancer blood test
May 13, 2024 1:48pm
New breast cancer guidelines call for first mammogram at age 40
May 2, 2024 3:15pm
Exact shows off its pill-on-a-string test for esophageal cancer
Mar 28, 2024 11:00am